Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Southern African HIV Clinicians Society guidelines for antiretroviral therapy in adults: 2020 update
Authors
Keywords
-
Journal
SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
Volume 21, Issue 1, Pages -
Publisher
AOSIS
Online
2020-09-17
DOI
10.4102/sajhivmed.v21i1.1115
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
- (2020) Gary Maartens SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Emtricitabine-associated red cell aplasia
- (2019) Karen Cohen et al. AIDS
- A lower dose of efavirenz can be co-administered with rifampicin and isoniazid in tuberculosis patients
- (2019) Julian P Kaboggoza et al. Open Forum Infectious Diseases
- Dolutegravir versus ritonavir-boosted lopinavir both with dual nucleoside reverse transcriptase inhibitor therapy in adults with HIV-1 infection in whom first-line therapy has failed (DAWNING): an open-label, non-inferiority, phase 3b trial
- (2019) Michael Aboud et al. LANCET INFECTIOUS DISEASES
- ART reduces T cell activation and immune exhaustion markers in HIV controllers
- (2019) Jonathan Z Li et al. CLINICAL INFECTIOUS DISEASES
- Long-term Outcomes in a Large Randomized Trial of HIV-1 Salvage Therapy: 96-week Results of AIDS Clinical Trials Group A5241 (OPTIONS)
- (2019) Rajesh T Gandhi et al. JOURNAL OF INFECTIOUS DISEASES
- Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
- (2019) Alison J Rodger et al. LANCET
- A systematic review of the genetic mechanisms of dolutegravir resistance
- (2019) Soo-Yon Rhee et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Neural-Tube Defects and Antiretroviral Treatment Regimens in Botswana
- (2019) Rebecca Zash et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
- (2019) Willem D.F. Venter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dolutegravir Use at Conception — Additional Surveillance Data from Botswana
- (2019) Mmakgomo M. Raesima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study
- (2019) Beatriz Grinsztejn et al. Lancet HIV
- Management of active tuberculosis in adults with HIV
- (2019) Graeme Meintjes et al. Lancet HIV
- Low-dose ritonavir-boosted darunavir once daily versus ritonavir-boosted lopinavir for participants with less than 50 HIV RNA copies per mL (WRHI 052): a randomised, open-label, phase 3, non-inferiority trial
- (2019) Willem D F Venter et al. Lancet HIV
- Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women
- (2019) Amita Gupta et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics of Efavirenz 400 mg Once Daily During Pregnancy and Post-Partum
- (2018) Mohammed Lamorde et al. CLINICAL INFECTIOUS DISEASES
- Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight)
- (2018) Jean-Michel Molina et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 and SWORD-2 studies
- (2018) Josep M Llibre et al. LANCET
- The unexpected success of NRTIs in second-line treatment
- (2018) Andrew M Hill et al. LANCET INFECTIOUS DISEASES
- Effect of HIV-1 low-level viraemia during antiretroviral therapy on treatment outcomes in WHO-guided South African treatment programmes: a multicentre cohort study
- (2018) Lucas E Hermans et al. LANCET INFECTIOUS DISEASES
- HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis
- (2018) Ravindra K Gupta et al. LANCET INFECTIOUS DISEASES
- An overview of tenofovir and renal disease for the HIV-treating clinician
- (2018) Willem D.F. Venter et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study
- (2018) Benjamin R Bavinton et al. Lancet HIV
- A clinical prediction rule for protease inhibitor resistance in patients failing second-line antiretroviral therapy
- (2018) Karen Cohen et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Third-Line Antiretroviral Therapy Program in the South African Public Sector
- (2018) Michelle Moorhouse et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
- (2018) Pedro Cahn et al. LANCET
- Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS
- (2018) Graeme Meintjes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Brief Report
- (2017) Ebrahim Variava et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting
- (2017) Christopher D. Pilcher et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Fixed-dose combination dolutegravir, abacavir, and lamivudine versus ritonavir-boosted atazanavir plus tenofovir disoproxil fumarate and emtricitabine in previously untreated women with HIV-1 infection (ARIA): week 48 results from a randomised, open-label, non-inferiority, phase 3b study
- (2017) Catherine Orrell et al. Lancet HIV
- Consensus statement: Management of drug-induced liver injury in HIV-positive patients treated for TB
- (2017) E Jong et al. SOUTHERN AFRICAN JOURNAL OF HIV MEDICINE
- Identification of a novel and severe pattern of efavirenz drug-induced liver injury in South Africa
- (2016) Mark W. Sonderup et al. AIDS
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy
- (2016) Alison J. Rodger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Population pharmacokinetic drug–drug interaction pooled analysis of existing data for rifabutin and HIV PIs
- (2016) Stefanie Hennig et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Antiretroviral Therapy for the Prevention of HIV-1 Transmission
- (2016) Myron S. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Initiating Antiretroviral Therapy for HIV at a Patient’s First Clinic Visit: The RapIT Randomized Controlled Trial
- (2016) Sydney Rosen et al. PLOS MEDICINE
- Cases of antiretroviral-associated gynaecomastia reported to the National HIV & Tuberculosis Health Care Worker Hotline in South Africa
- (2016) Christine Njuguna et al. AIDS Research and Therapy
- Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study
- (2016) Alberto M La Rosa et al. Lancet HIV
- Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial
- (2016) Gideon Amanyire et al. Lancet HIV
- Therapy-Emergent Drug Resistance to Integrase Strand Transfer Inhibitors in HIV-1 Patients: A Subgroup Meta-Analysis of Clinical Trials
- (2016) Jiangzhou You et al. PLoS One
- Optimal Timing of Antiretroviral Therapy Initiation for HIV-Infected Adults With Newly Diagnosed Pulmonary Tuberculosis
- (2015) Olalekan A. Uthman et al. ANNALS OF INTERNAL MEDICINE
- Pharmacogenetics of plasma efavirenz exposure in HIV-infected adults and children in South Africa
- (2015) Phumla Z. Sinxadi et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study
- (2015) LANCET INFECTIOUS DISEASES
- Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa
- (2015) NEW ENGLAND JOURNAL OF MEDICINE
- Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
- (2015) Graeme Meintjes et al. AIDS Research and Therapy
- Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis
- (2015) Mark A Boyd et al. Lancet HIV
- Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study
- (2015) Jean-Michel Molina et al. Lancet HIV
- Social and ethical implications of HIV cure research
- (2014) Joseph D. Tucker et al. AIDS
- Rilpivirine Versus Efavirenz with Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment-Naïve HIV-1–Infected Patients with HIV-1 RNA ≤100,000 Copies/mL: Week 96 Pooled ECHO/THRIVE Subanalysis
- (2014) Georg Behrens et al. AIDS PATIENT CARE AND STDS
- Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America
- (2014) Gregory M. Lucas et al. CLINICAL INFECTIOUS DISEASES
- Virological efficacy of abacavir: systematic review and meta-analysis
- (2014) M. Cruciani et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Hospitalization Rates and Reasons Among HIV Elite Controllers and Persons With Medically Controlled HIV Infection
- (2014) Trevor A. Crowell et al. JOURNAL OF INFECTIOUS DISEASES
- Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial
- (2014) Molebogeng X Rangaka et al. LANCET
- Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa
- (2014) Nicholas I. Paton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis
- (2014) David R. Boulware et al. NEW ENGLAND JOURNAL OF MEDICINE
- Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation
- (2013) C. Laprise et al. CLINICAL INFECTIOUS DISEASES
- Evidence for Innate Immune System Activation in HIV Type 1–Infected Elite Controllers
- (2013) Sonya Krishnan et al. JOURNAL OF INFECTIOUS DISEASES
- Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study
- (2013) Pedro Cahn et al. LANCET
- Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial
- (2013) François Raffi et al. LANCET INFECTIOUS DISEASES
- Dolutegravir plus Abacavir–Lamivudine for the Treatment of HIV-1 Infection
- (2013) Sharon L. Walmsley et al. NEW ENGLAND JOURNAL OF MEDICINE
- Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
- (2013) Leigh F. Johnson et al. PLOS MEDICINE
- Week 96 efficacy and safety of rilpivirine in treatment-naive, HIV-1 patients in two Phase III randomized trials
- (2012) Calvin J. Cohen et al. AIDS
- The Safety, Effectiveness and Concentrations of Adjusted Lopinavir/Ritonavir in HIV-Infected Adults on Rifampicin-Based Antitubercular Therapy
- (2012) Eric H. Decloedt et al. PLoS One
- Should We Treat Acute HIV Infection?
- (2012) Meagan O’Brien et al. Current HIV/AIDS Reports
- Week 48 analysis of once-daily vs. twice-daily darunavir/ritonavir in treatment-experienced HIV-1-infected patients
- (2011) Pedro Cahn et al. AIDS
- No Risk of Myocardial Infarction Associated With Initial Antiretroviral Treatment Containing Abacavir: Short and Long-Term Results from ACTG A5001/ALLRT
- (2011) H. J. Ribaudo et al. CLINICAL INFECTIOUS DISEASES
- Timing of Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus (HIV)-Associated Tuberculous Meningitis
- (2011) M. E. Torok et al. CLINICAL INFECTIOUS DISEASES
- Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies
- (2011) Haileyesus Getahun et al. PLOS MEDICINE
- Efavirenz directly modulates the oestrogen receptor and induces breast cancer cell growth
- (2010) MJ Sikora et al. HIV MEDICINE
- Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study
- (2010) Jean-Michel Molina et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- A CD4+ Cell Count
- (2010) Mona R Loutfy et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions
- (2010) Lewis J Haddow et al. LANCET INFECTIOUS DISEASES
- Once-daily darunavir/ritonavir vs. lopinavir/ritonavir in treatment-naive, HIV-1-infected patients: 96-week analysis
- (2009) Anthony M Mills et al. AIDS
- High Rate of Virologic Suppression with Raltegravir plus Etravirine and Darunavir/Ritonavir among Treatment‐Experienced Patients Infected with Multidrug‐Resistant HIV: Results of the ANRS 139 TRIO Trial
- (2009) Y. Yazdanpanah et al. CLINICAL INFECTIOUS DISEASES
- Will Etravirine Work in Patients Failing Nonnucleoside Reverse Transcriptase Inhibitor-Based Treatment in Southern Africa?
- (2009) Wendy S Stevens et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Mortality Associated With Discordant Responses to Antiretroviral Therapy in Resource-Constrained Settings
- (2009) Suely Hiromi Tuboi et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Early Antiretroviral Therapy Reduces AIDS Progression/Death in Individuals with Acute Opportunistic Infections: A Multicenter Randomized Strategy Trial
- (2009) Andrew R. Zolopa et al. PLoS One
- Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
- (2008) Graeme Meintjes et al. LANCET INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More